These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 27875419

  • 1. New treatment options for irritable bowel syndrome with predominant diarrhea.
    Weber HC.
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):25-30. PubMed ID: 27875419
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS.
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [Abstract] [Full Text] [Related]

  • 7. Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS.
    Lacy BE.
    Neurogastroenterol Motil; 2016 Jan; 28(1):26-35. PubMed ID: 26690872
    [Abstract] [Full Text] [Related]

  • 8. Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome.
    Scarpellini E, Laterza L, Ianiro G, Tack J, Abenavoli L, Gasbarrini A.
    Expert Opin Pharmacother; 2016 Jul; 17(10):1395-402. PubMed ID: 27267380
    [Abstract] [Full Text] [Related]

  • 9. Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea.
    Brenner DM, Sayuk GS.
    Adv Ther; 2020 Jan; 37(1):83-96. PubMed ID: 31707713
    [Abstract] [Full Text] [Related]

  • 10. Targeted pharmacotherapy of irritable bowel syndrome.
    Arokiadoss A, Weber HC.
    Curr Opin Endocrinol Diabetes Obes; 2021 Apr 01; 28(2):214-221. PubMed ID: 33481423
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome.
    Özdener AE, Rivkin A.
    Drug Des Devel Ther; 2017 Apr 01; 11():2827-2840. PubMed ID: 29033544
    [Abstract] [Full Text] [Related]

  • 14. Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide.
    Brenner DM, Sayuk GS, Abel JL, Burslem K.
    J Manag Care Spec Pharm; 2021 Apr 01; 27(4):469-477. PubMed ID: 33769858
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline.
    Corsetti M, Whorwell P.
    Expert Rev Gastroenterol Hepatol; 2017 Apr 01; 11(4):285-292. PubMed ID: 28276811
    [Abstract] [Full Text] [Related]

  • 18. Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.
    Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS.
    Am J Gastroenterol; 2017 Feb 01; 112(2):365-374. PubMed ID: 27922029
    [Abstract] [Full Text] [Related]

  • 19. Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective.
    Vera I, Júdez FJ.
    Rev Esp Enferm Dig; 2017 Nov 01; 109(11):788-794. PubMed ID: 28747053
    [Abstract] [Full Text] [Related]

  • 20. Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea.
    Fant RV, Henningfield JE, Cash BD, Dove LS, Covington PS.
    Clin Gastroenterol Hepatol; 2017 Jul 01; 15(7):1021-1029.e6. PubMed ID: 28167156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.